Text Size
7 studies found for:    FGG

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva
Condition: Gingival Recession
Interventions: Device: Gintuit;   Other: autologous Free Gingival Graft (FGG)
2 Recruiting A 26-week Treatment Randomized, Double-blind, Double Dummy, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of QVA149 (Indacaterol / Glycopyrronium Bromide) Compared to Fluticasone/Salmeterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QVA149;   Drug: Fluticasone/salmeterol;   Drug: Pacebo to QVA149;   Drug: Placebo to fluticasone/salmeterol
3 Recruiting Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
Conditions: Coronary Artery Disease (CAD);   Coronary Atherosclerosis
Interventions: Drug: Placebo;   Drug: Aliskiren
4 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
5 Active, not recruiting Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints Including 12 Month Safety Follow-up Off-treatment
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Disease
Interventions: Drug: Aliskiren;   Drug: Placebo
6 Recruiting Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-mortality in Patients With Chronic Heart Failure
Condition: Chronic Heart Failure
Interventions: Drug: Enalapril monotherapy;   Drug: Aliskiren monotherapy;   Drug: Aliskiren / Enalapril combination therapy
7 Terminated Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Condition: Coronary Artery Disease
Interventions: Drug: Apadenoson SPECT-MPI;   Drug: Adenosine SPECT-MPI
To Top

† Indicates status has not been verified in more than two years